Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2007
02/13/2007CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
02/13/2007CA2387198C Method for treating hair loss using thyromimetic compounds
02/13/2007CA2361288C Mutual prodrug of amlodipine and atorvastatin
02/13/2007CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/13/2007CA2220649C 4-hydroxy-piperidine derivatives
02/13/2007CA2122236C Quinolines and their analogs
02/08/2007WO2007016674A2 2-aminoaryl pyridines as protein kinases inhibitors
02/08/2007WO2007016354A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/08/2007WO2007015871A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
02/08/2007WO2007015870A2 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
02/08/2007WO2007015162A1 Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
02/08/2007WO2007015017A2 Novel polyquinoline derivatives and the therapeutic use thereof
02/08/2007WO2007014923A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007WO2007014922A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007WO2007014921A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007WO2007014885A1 Antibacterial quinoline derivatives
02/08/2007WO2007014851A2 Indol-3-yl-carbonyl-piperidin and piperazin derivatives
02/08/2007WO2006129168A3 Bicyclic derivatives for the treatment of abnormal cell growth
02/08/2007WO2006113704A3 Subtituted heteroaryl cb1 antagonists
02/08/2007WO2006100026A8 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
02/08/2007WO2006091702A3 Multimediator dopamine transport inhibitors, and uses related thereto
02/08/2007WO2006071775A3 Novel compounds useful for bradykinin b1 receptor antagonism
02/08/2007US20070032656 Use of metal complex compounds as oxidation catalysts
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
02/08/2007US20070032640 Cytokine receptor
02/08/2007US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis
02/08/2007US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
02/08/2007US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia
02/08/2007US20070032523 Chemical compounds
02/08/2007US20070032520 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/08/2007US20070032508 Quinazoline derivatives as tyrosine kinase inhibitors
02/08/2007US20070032507 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug.
02/08/2007US20070032497 Fused-ring compounds and use thereof as drugs
02/08/2007US20070032492 Cytokine Inhibitors
02/08/2007US20070032490 N-Phenyl-'(4-pyridyl)-azinyl!amine derivatives as plant protection agents
02/08/2007US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
02/08/2007US20070032488 6-Membered aryl and heteroaryl derivatives for treating viruses
02/08/2007US20070032434 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
02/08/2007US20070031973 Triazine derivatives as universal peptide isotope tag reagents (U-PIT)
02/08/2007US20070031854 Novel 10,10'-substituted-9,9'-biacridilidine luminescent molecules their preparation and uses
02/08/2007DE102005035575A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
02/08/2007CA2823946A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
02/08/2007CA2617654A1 Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
02/08/2007CA2617413A1 2-aminoaryl pyridines as protein kinases inhibitors
02/08/2007CA2617099A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007CA2617096A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007CA2616937A1 Indol-3-yl-carbonyl-piperidin and piperazin derivatives
02/08/2007CA2616453A1 Novel polyquinoline derivatives and the therapeutic use thereof
02/08/2007CA2616159A1 Benzimidazoles useful as inhibitors of protein kinases
02/08/2007CA2615669A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
02/08/2007CA2615574A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/08/2007CA2614981A1 Antibacterial quinoline derivatives
02/08/2007CA2614334A1 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
02/07/2007EP1749827A1 Anti-tumor agent
02/07/2007EP1749824A1 Benzodiazepine derivatives, their preparation and the therapeutic use thereof
02/07/2007EP1748998A1 A novel stereoselective synthesis of benzimidazole sulfoxides
02/07/2007EP1748987A2 2-propene-1-ones as hsp 70 inducers
02/07/2007EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
02/07/2007EP1748984A1 Piperidine derivatives as nk1 and nk3 antagonists
02/07/2007EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease
02/07/2007EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists
02/07/2007EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase
02/07/2007EP1651622B1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds
02/07/2007EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity
02/07/2007EP1501504B1 1-substituted imidazole derivatives as nos inhibitors
02/07/2007EP1401813B1 New indole derivatives with 5-ht6 receptor affinity
02/07/2007EP1387849B1 Polymerisation catalyst
02/07/2007EP1242382B1 Tricyclic protein kinase inhibitors
02/07/2007EP1185525B1 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
02/07/2007EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same
02/07/2007CN1910181A Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
02/07/2007CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
02/07/2007CN1910173A Indolylmaleimide derivatives as PKC inhibitors
02/07/2007CN1910172A 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
02/07/2007CN1910171A Method for preparation of 6-11 bicyclo erythromycin derivant
02/07/2007CN1910151A Cyclic amine derivative with heteroaryl ring
02/07/2007CN1909907A Quinoline derivatives and use thereof as mycobacterial inhibitors
02/07/2007CN1909906A 2,6-disubstituted piperidines as modulators of chemokine receptor activity
02/07/2007CN1909904A 4-aryl piperidines
02/07/2007CN1909897A Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
02/07/2007CN1907982A New compounds useful for the treatment of obesity,type II diabetes and CNS disorders
02/07/2007CN1907968A Method for making 4-(3,4-dichlorophenoxy)piperidine
02/07/2007CN1298715C Non-imidazole compounds as histamine H3 antagonists
02/07/2007CN1298706C Insecticidal diamides
02/07/2007CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them
02/07/2007CN1298704C Isatine derivatives with neurotrophic activity
02/07/2007CN1298703C Cyanopyrolidine derivatives
02/07/2007CN1298322C Crystalline solids of carvedilol and processes for their preparation
02/06/2007US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides
02/06/2007US7173054 Respiratory syncytial virus replication inhibitors
02/06/2007US7173051 Inhibitors of cathepsin S
02/06/2007US7173048 Indolyl derivatives as liver-X-receptor (LXR) modulators
02/06/2007US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands
02/06/2007US7173046 CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications
02/06/2007US7173045 Drugs for forming medicines such as analgesics formed by oximation and basification
02/06/2007US7173042 Quinoline inhibitors of cGMP phosphodiesterase
02/06/2007US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/06/2007US7173038 Treatment of diseases such as cancer or arthritis
02/06/2007US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis